| Criterion Text | Inclusion/Exclusion | Disease | Biomarker | Prior Therapy | Criterion Rule |
| --- | --- | --- | --- | --- | --- |
| At least 12 weeks of single-agent durvalumab | Inclusion | None | None | Durvalumab | Durvalumab_single_agent_12_weeks |